FDA designates LSD-based drug as possible breakthrough treatment for anxiety
March 7 (UPI) -- A psychedelic medicine biotech company announced Thursday its LSD-based drug has won U.S. Food and Drug Administration breakthrough treatment status...
FDA Grants Breakthrough Therapy Status To LSD Drug To Treat Anxiety
The U.S. Food and Drug Administration last week granted “breakthrough therapy” status to a form of the psychedelic drug LSD as a treatment for...
Mayo Clinic Minute: Advances in multiple myeloma treatment
Mayo Clinic Minute
March 12, 2024
March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often...
a new era in mental health treatment
Once stigmatized, mental health conditions like anxiety, depression, schizophrenia, and post-traumatic stress disorder are now gaining recognition in society thanks to years of research...
Business Courier: UC researcher pumped about breakthrough for treatment of heart...
Jack Rubinstein, MD, is the chief medical officer launching TRPV Pharmaceuticals, a company dedicated to advancing a therapeutic approach for...
Bispecific Antibodies Represent DLBCL Treatment Breakthrough
Bispecific antibodies (BsAbs) have encouraging response rates along with a manageable safety profile in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL), according...
FMI Reveals Biomarker-driven Breakthroughs! Companion Diagnostic Tests Unlock Precision Treatment with...
US PARP inhibitor market to grow steadily at 11.2%. Personalized medicine & strong R&D fuel innovation despite regulatory hurdles. PARP inhibitors are primarily used...
Advancements in Hemophilia A Therapies: Altuviiio and Roctavian
This is a video synopsis/summary of an Insights featuring Steven W. Pipe, MD.Pipe introduces the latest hemophilia A therapies, Altuviiio and Roctavian, shedding light...